BRAF and Langerhans cell histiocytosis: Although there is a case report indicating progression from LCH to LCS [135] and case reports of detection of BRAF mutation in LCS [136, 137], these two diseases are not in the same spectrum considering age distribution, neoplastic cell morphology, inflammatory granuloma, and cytokine storm release.